Novo Nordisk A/S Current Assets

The latest current assets for NOVC.DE is $210B as of June 2026. That compares with $160B in the prior-year period — up 28.3% year over year. Investors often review this figure alongside Novo Nordisk A/S's historical trend and sector peers before judging valuation or financial health.

Over the past year, NOVC.DE's current assets moved from $160B to $210B — a 28.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Novo Nordisk A/S's operating scale or balance-sheet position.

A current assets figure of $210B for NOVC.DE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NOVC.DE's current assets ($210B), review year-over-year change from $160B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Novo Nordisk A/S's current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.